Dec 14, 2023
Rapid Commercialization Partners (RCP), a leader in the commercial acceleration of advanced biotechnology therapies, will be attending the NewYorkBIO Life Science Company Showcase - Aardvark Therapeutics to present; and announces expansion to medical device team.
CAMBRIDGE, Mass. - Dec. 14, 2023 - PRLog -- RCP announced today they'll be attending NewYorkBIO's Life Science Company Showcase at the New York Stock Exchange as a sponsor and in support of client, Aardvark Therapeutics. Aardvark is a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation, and other indications. Aardvark is looking at the interaction between the biology of the digestive tract and the brain that is mediated through the vagus nerve.
"We're delighted to be here as a sponsor and to support Chief Business Officer Bryan Jones and the remarkable team at Aardvark Therapeutics," said Christina Ansted, Co-Founder and CEO of Rapid Commercialization Partners. "The potential for development and commercialization of therapies emerging from their science – notably in indications like obesity and Prader-Willi Syndrome - are quite promising."
"We're also excited to announce the expansion of RCP's focus within the medical device and technology sector," added Ms. Ansted. "Terry Murray, a 35-year veteran of the medical device industry, is joining our executive team as Chief Strategy Officer, Medical Device & Technology. We're excited to expand our capabilities in MedTech and Terry will be an integral part of that development."
"I'm thrilled to be joining such an exceptional team of experts and professionals here in Cambridge," commented Terry. "I started my sales career calling on MIT and Harvard BioLabs back in the late eighties. Having the privilege of joining the RCP team feels like I've come full circle. Being back in Harvard Square is like a homecoming."
Terry's decades of experience include senior executive positions with STERIS Corporation and SPX Corporation and more than twenty years of working to commercialize investor-driven startups in the medical device and life science fields. Terry also brings extensive experience from engineering and manufacturing firms dedicated the design and development of medical technologies.
RCP was founded to bring a legacy of innovation to the commercialization of biotech products. Comprised of executive-level experts from critical functional areas within commercial biotechnology and medical device, we work as an integrated, but fractional extension of our client partners to build the commercial foundation, address observable inefficiency and bring needed therapies, technologies, and devices to patients faster and with improved fiscal responsibility.
RCP is headquartered in historic Harvard Square, in the heart of Cambridge, Massachusetts - a city world-renowned for its academic institutions and vibrant biotechnology community.
For more information, please contact [email protected].
© 2023, Rapid Commercialization Partners, Inc.
For more than two decades, DealBook has scored scoops and high-profile interviews.
Highlights from the annual gathering of leaders from the world of business, politics and culture.
Defense companies are facing calls to increase production, cut costs and keep pace with rapidly evolving technology as the Russian threat intensifies.
The Bipartisan Policy Center estimates that the United States will soon run up against a limit to how much debt it can issue.
About 23,000 households use heating oil in Northumberland and face increasing bills this winter.
The same tech start-up that discovered a PHP flaw used AI to uncover a critical software bug in one of the world's most popular computer language programs.
A new Metro desk series aims to document the lives of people who perform underrecognized jobs in one of the world’s busiest cities.
Public displays of friendship contrast with mounting trade and investment restrictions, highlighting the widening rift between the two economies.
The amendment is being brought forward by deputies Gavin St Pier and Tom Rylatt.
The former Nvidia chief executive has been at the centre of the artificial intelligence boom.
After its fraught takeover of steel maker U.S. Steel, a Japanese manufacturer is attempting to revitalize the American company’s facilities, including its oldest mill outside Pittsburgh.
The Amazon chairman says he was originally "biased against" Pattinson "because he's already so famous".
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.